Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

CHF Solutions, Inc (CHFS)

Add CHFS Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/5/2017 8:11:32 AM - Followers: 34 - Board type: Free - Posts Today: 0

Sunshine Heart
Corporate Office
United States of America
Sunshine Heart, Inc.
12988 Valley View Road
Eden Prairie, MN 55344
Phone +1 952 345 4200
Dr Elaine Stead
Vice President, Corporate Development
+61 (0) 412 637 023

Sunshine Heart focuses on an innovative cardiac assist therapy to treat heart patients who represent a large and under-served market segment and provide a significant opportunity for the company. Unfortunately, these Class IV patients, despite optimal drug therapy, have persistent symptoms and their options are very limited. Surgical approaches usually involve complex open-heart surgery or heart transplantation.
C-Pulse systemSunshine Heart's C-Pulse® Heart Assist System is an innovative approach to assist the heart's function, not replace it and may be implanted using a minimally invasive approach. The C-Pulse Heart Assist System is designed to treat clinical symptoms associated with Class III and ambulatory Class IV heart failure, sometimes also referred to as moderate and severe failure. Patients associated with Class III and ambulatory Class IV heart failure are typically unable to engage in normal activities, compromising their quality of life.


The C-Pulse Heart assist system is designed to treat clinical symptoms associated with Class III and ambulatory Class IV heart failure. These symptoms normally include shortness of breath, dizziness, low blood pressure and fluid retention. Patients associated with Class III and ambulatory Class IV heart failure are typically unable to engage in normal activities, compromising their quality of life. The C-Pulse Heart Assist System may be implanted through a minimally invasive or full sternotomy technique. 

The C-Pulse System's design is based on proven balloon counter-pulsation technology to assist the heart by reducing the workload of the left ventricle. During inflation of the balloon, blood flow is increased to the coronary arteries, thereby providing additional oxygen which is vital to a failing heart. During deflation, theworkload or pumping required by the left heart is reduced. The balloon inflation and deflation is synchronized to the patient's ECG, similar to a pacemaker. Potential benefits of the technology, which are currently being analyzed in clinical trials, are relief of shortness of breath, increased physical activity, and improved cardiac function.

The C-Pulse is designed to improve heart function in three ways:


More blood flow from the heart called increased cardiac output


More oxygen to the heart muscle, called increased coronary blood flow


Less work for the heart, called decreased afterload

Shares Outstanding:6.28M
Free trading shares: 2.62M

Latest news:
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire -06/07/12)- Sunshine Heart, Inc. (SSH) (SHC.AX), a global medical device company focused on innovative technologies for moderate to severe heart failure, today announced that the company has been granted approval by Health Canada to use its next generation C-Pulse® Heart Assist System driver in ongoing clinical studies at Royal Victoria Hospital. The new C-Pulse driver is designed to provide heart failure patients with enhanced patient comfort and performance. The C-Pulse System is a new investigational therapeutic approach based on proven balloon counter-pulsation technology for the treatment of patients with Class III and ambulatory Class IV heart failure.
The C-Pulse driver now comes as a single unit that is half the size, lighter and quieter than the first generation technology. The driver also features a number of software enhancements. The C-Pulse System is currently in an investigational study at Royal Victoria Hospital. The prospective study is designed to evaluate the safety and performance of the C-Pulse System as a treatment for patients with moderate to severe heart failure. To date, four patients have been implanted with the initial C-Pulse System. The company has received Health Canada approval to expand the number of participants in the trial to 20 patients. All trial participants will receive the new C-Pulse driver, which will be used in ongoing and future clinical studies.
"We are pleased to have received Health Canada approval of our next generation C-Pulse driver technology for clinical use," said Dave Rosa, CEO of Sunshine Heart. "We enhanced the driver based on results from our feasibility trial and feedback from physicians and patients. With the reduced size, weight and noise reduction, we expect improvements in patient quality of life due to enhanced comfort and performance. We look forward to making this new technology available to patients enrolled in our clinical studies in Canada in the coming weeks, as well the United States and Europe thereafter."
The external C-Pulse driver inflates and deflates the balloon which is secured by a cuff around the outside of the ascending aorta, the main blood vessel of the heart. The cuff and heart signal sensing wires are attached to the external C-Pulse driver, which inflates and deflates the balloon in sequence with the electrocardiogram (ECG) signal to assist heart function and the pumping capacity of the heart. The balloon deflects the aorta in a "thumb-printing" manner, which is intended to minimize aortic wall strain and maximize blood volume displacement per beat.
About Class III Heart Failure
Heart failure is a common condition in which the heart becomes unable to pump sufficient blood to meet the body's needs. More than five million people in the United States have heart failure, resulting in more than 300,000 deaths each year(1). Heart failure is a progressive condition and typically results from damage to the heart muscle arising from a heart attack or virus.
Cardiologists use the New York Heart Association (NYHA) classification system to define the four classes of heart failure; each class is determined by rating a patient's symptoms to everyday activities and quality of life. More than 1.5 million U.S. heart failure patients are in the Class III or moderate heart failure category which is defined by the limitation of physical activity(2). These patients are comfortable at rest, but levels of activity regarded as less than ordinary cause fatigue, palpitation and/or shortness of breath. The most common treatments for Class III heart failure are drugs, lifestyle adjustments, family education, device therapy (i.e. heart failure pacemaker with or without a defibrillator) or surgery. These standard treatments often do not resolve the progression of heart failure leaving patients without any additional options, hence the need for new treatments for patients living with the disease.
Caution - Investigational device. Limited by Federal (or United States) law to investigational use.
SSH chart

Preliminary Data from european trial, delivered at the 34th Annual International Society for Heart and Lung Transplant April 10th, 2014
Surgical implantation was successful in all patients and does not require cardiopulmonary bypass. Follow-up ranges from 5 days - 6 months with a cumulative follow-up of 493 days. No stroke, myocardial infarction, major bleeding or major infection has occurred due to the device. One patient developed tachycardia with worsening heart failure 12 hours after surgery without stabilization under medication and underwent left ventricular assist device implantation after 5 days.
4 patients improved clinically under the C-Pulse system with three patients improving their functional status by one NYHA class. So far LVEF has increased by an average of 10-15% in the 3 patients with the longest follow-up. One patient is post-op day 7 and has not yet been assessed for efficacy. Conclusion: The C-Pulse system seems to be a promising therapeutic option and may improve cardiac function over time.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SSH News: Current Report Filing (8-k) 06/09/2017 04:22:10 PM
SSH News: Statement of Changes in Beneficial Ownership (4) 06/06/2017 05:00:52 PM
SSH News: Statement of Changes in Beneficial Ownership (4) 06/06/2017 04:49:34 PM
SSH News: Statement of Changes in Beneficial Ownership (4) 06/06/2017 04:37:00 PM
SSH News: Statement of Changes in Beneficial Ownership (4) 06/06/2017 04:28:44 PM
#666   CHFS...CHF Solutions annoucnes publication of clinical trials using georgie18 06/05/17 08:11:32 AM
#665   Yup...watching for that gap to fill... georgie18 05/24/17 11:07:37 AM
#664[/ Jugas 05/24/17 11:02:38 AM
#663   Sunshine Heart Announces Company Name Change to CHF georgie18 05/23/17 08:04:10 AM
#662   ssh low float, volume can send this to rma6312 05/22/17 12:09:30 PM
#661   SSH... .82 Hits in pre market... georgie18 05/12/17 08:22:29 AM
#660   SSH...75 ...Gap Down Chart...Psar flipped to a bullish georgie18 05/12/17 06:23:42 AM
#659   What a great day. More to come. SSH! gsobes 05/11/17 06:51:53 PM
#658   Good timing, we rollin'. Wildbilly 05/11/17 01:51:48 PM
#657   SSH .75 vol pop ClearlyStocks 05/11/17 01:43:45 PM
#656   Added as well. Low float big potential gsobes 05/11/17 01:32:15 PM
#655   Adding SSH @ $.645, close enough to bottom Wildbilly 05/11/17 09:40:29 AM
#654   SSH float 1.64m ( post r/s), short 50%? wowzer Wildbilly 05/10/17 08:05:44 AM
#653   Lots of Money watching...$2-3 in the morning if VERITAS77 05/08/17 02:30:01 PM
#652   SHORT SQUEEZE $5-10....IMO. VERITAS77 05/08/17 10:20:40 AM
#651   Who says it cant maintain 1$ ? Thats stock1ace1 05/06/17 10:49:46 PM
#650   Right I'm aware I read filings of every PLelek 05/06/17 03:10:17 PM
#649   SSH, Sunshine Heart, Inc. announced today that on Bernija1 05/06/17 03:08:10 PM
#648   haha Great t shirt ima have to get stock1ace1 05/06/17 02:50:04 PM
#647   Too bad it's been under a $1 for PLelek 05/06/17 01:08:06 PM
#646 [SMART MONEY] 05/06/17 10:22:45 AM
#645   Out for a small loss. Did not get no shorts 05/05/17 12:27:41 PM
#644   Need volume, ssh Bernija1 05/05/17 10:25:56 AM
#643   1.50+ or more today imo mrpickem 05/05/17 08:51:49 AM
#642   Yup. All the making of a huge short no shorts 05/05/17 08:48:48 AM
#641   ***** Short Squeeze Today ****** stock1ace1 05/05/17 08:46:11 AM
#640   Huge 8 k out ! stock1ace1 05/05/17 08:43:18 AM
#639   Sunshine Heart Files 8K - Other Events >SSH 5/5/17, DJ2NAZTY 05/05/17 08:35:16 AM
#638   Yes! Gonna be a solid day DJ2NAZTY 05/05/17 08:34:05 AM
#637   wow is this correct? 50% short = [SMART MONEY] 05/05/17 08:29:55 AM
#636   News... low float. We may have a runner today no shorts 05/05/17 08:18:24 AM
#635   No this thing fell hard. Today didn't fix it... Hazmat927d 05/05/17 04:03:08 AM
#634   r u getting better now? sup105 05/04/17 07:11:56 PM
#633   In near the same level. Just the start no shorts 05/04/17 01:20:37 PM
#632   in earlier at .75 CENTS zino 05/04/17 01:12:34 PM
#631   I sold last week lol Goldmind 05/02/17 09:14:12 AM
#630   Yes im sure enjoy SSH lol stock1ace1 05/02/17 08:21:44 AM
#629   Wow. Really kicking myself in the ass for Hazmat927d 04/26/17 11:19:36 AM
#628   Are you sure about that?:) Goldmind 04/26/17 09:13:05 AM
#627   4$ not coming new 52 week lows coming stock1ace1 04/26/17 08:21:07 AM
#626   $1.03 Aftermarket! !!!!!! Goldmind 04/20/17 06:00:22 PM
#625   Wow!!!!!!! Goldmind 04/20/17 05:47:27 PM
#624   Major of company buy 1.3m shares!!!!!!!!!! Weeeeeeeeee Goldmind 04/20/17 05:09:59 PM
#623   $4 coming !!!!!!!! Goldmind 04/20/17 05:09:18 PM
#622   Please sell now!!! Goldmind 04/20/17 11:48:04 AM
#621   Sell now!!!!! Company is bankrupt out of money: ( Goldmind 04/20/17 11:44:53 AM
#620   News!!!!!! Company has been delisted. Sell now !!! Goldmind 04/20/17 11:21:58 AM
#619   I'm out Goldmind 04/20/17 09:43:37 AM
#618   Goldmind, I bought back in @ 0.915 late pennyvestor 04/19/17 04:21:29 PM
#617   I'm in ;) Goldmind 04/19/17 03:32:38 PM